Addex Therapeutics Ltd. Form 6-K Summary
Business Context and Reporting Period
Addex Therapeutics Ltd., a foreign private issuer based in Geneva, Switzerland, filed this Form 6-K on April 8, 2020. The filing serves to distribute the company's 2019 Annual Report (SIX Annual Report) for the fiscal year ended December 31, 2019, which was originally filed with the SIX Swiss Exchange.
Key Financial Metrics
This Form 6-K is a cover document and does not contain specific financial data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached 2019 Annual Report for these details.
Material Changes
The filing does not disclose specific material changes or comparative financial performance versus prior periods within this document.
Guidance, Outlook, and Risks
No management commentary, forward-looking guidance, risk factors, or contingencies are detailed in this specific Form 6-K text. The document solely references the availability of the full annual report.
Investor Verification Checklist
- Access the full 2019 Annual Report via the "Investors" section of www.Addextherapeutics.com to review detailed financial statements.
- Verify the press release dated April 8, 2020 (Exhibit 99.1) for any immediate operational updates.
- Confirm the company's continued listing status on the SIX Swiss Exchange.